4//SEC Filing
Matrix Capital Management Company, LP 4
Accession 0000902664-21-001835
CIK 0001478320other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 7:45 PM ET
Size
26.8 KB
Accession
0000902664-21-001835
Insider Transaction Report
Form 4
GOEL DAVID E.
Director10% OwnerOther
Transactions
- Sale
Common Stock
2021-03-08$39.22/sh−75,000$2,941,163→ 12,805,795 total(indirect: See footnotes) - Sale
Common Stock
2021-03-08$38.22/sh−234,295$8,954,310→ 12,880,795 total(indirect: See footnotes) - Sale
Common Stock
2021-03-08$39.97/sh−33,600$1,343,039→ 12,772,195 total(indirect: See footnotes) - Sale
Common Stock
2021-03-08$41.21/sh−71,194$2,933,641→ 12,701,001 total(indirect: See footnotes) - Sale
Common Stock
2021-03-08$41.62/sh−85,911$3,575,753→ 12,615,090 total(indirect: See footnotes) - Sale
Common Stock
2021-03-09$40.42/sh−215,698$8,719,333→ 12,399,392 total(indirect: See footnotes) - Sale
Common Stock
2021-03-09$41.16/sh−34,302$1,411,887→ 12,365,090 total(indirect: See footnotes) - Sale
Common Stock
2021-03-10$41.47/sh−25,732$1,067,037→ 12,339,358 total(indirect: See footnotes) - Sale
Common Stock
2021-03-10$42.38/sh−30,268$1,282,664→ 12,309,090 total(indirect: See footnotes)
Holdings
- 1,504
Common Stock
Matrix Capital Management Company, LP
Director10% OwnerOther
Transactions
- Sale
Common Stock
2021-03-09$40.42/sh−215,698$8,719,333→ 12,399,392 total(indirect: See footnotes) - Sale
Common Stock
2021-03-08$39.22/sh−75,000$2,941,163→ 12,805,795 total(indirect: See footnotes) - Sale
Common Stock
2021-03-08$41.62/sh−85,911$3,575,753→ 12,615,090 total(indirect: See footnotes) - Sale
Common Stock
2021-03-09$41.16/sh−34,302$1,411,887→ 12,365,090 total(indirect: See footnotes) - Sale
Common Stock
2021-03-08$38.22/sh−234,295$8,954,310→ 12,880,795 total(indirect: See footnotes) - Sale
Common Stock
2021-03-08$39.97/sh−33,600$1,343,039→ 12,772,195 total(indirect: See footnotes) - Sale
Common Stock
2021-03-08$41.21/sh−71,194$2,933,641→ 12,701,001 total(indirect: See footnotes) - Sale
Common Stock
2021-03-10$41.47/sh−25,732$1,067,037→ 12,339,358 total(indirect: See footnotes) - Sale
Common Stock
2021-03-10$42.38/sh−30,268$1,282,664→ 12,309,090 total(indirect: See footnotes)
Holdings
- 1,504
Common Stock
Footnotes (11)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $37.8275 to $38.825, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
- [F10]The securities reported herein are held by Matrix Capital Management Master Fund, LP (the "Matrix Fund"). Matrix Capital Management Company, LP (the "Investment Manager"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel ("Mr. Goel", and together with the Investment Manager, the "Reporting Persons"), serves as the Managing General Partner of the Investment Manager.
- [F11]The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.83 to $39.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $39.845 to $40.465, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
- [F4]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40.49 to $41.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
- [F5]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41.495, to $41.945, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
- [F6]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40 to $41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
- [F7]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41.005 to $41.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
- [F8]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41 to $42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
- [F9]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $42.01 to $42.685, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
Documents
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001410830
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 7:45 PM ET
- Size
- 26.8 KB